Inhibitory effect of resveratrol on the growth and angiogenesis of human endometrial tissue in an In Vitro three-dimensional model of endometriosis
Lab / animal
OA: closed
CC0
⤵ 20 in-corpus citations
AI-generated summary
Resveratrol was found to inhibit the growth and angiogenesis of human endometrial tissue within an in vitro three-dimensional model of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a chronic estrogen-dependent disorder and one of the most common causes of infertility in women. Resveratrol (RES) is a polyphenolic and phytoestrogenic compound with anti-oxidative, anti-inflammatory, anti-angiogenic, and anti-estrogenic properties. The aim of the present study was to investigate the effect of different concentrations of RES on human endometrial growth and angiogenesis in an in vitro three-dimensional (3D) model of endometriosis.Human endometrial tissues of endometriosis (endometriotic) and normal (endometrial) subjects (n = 9/groups) were biopsied in sterile conditions and cut into 1 × 2 mm pieces. Tissue fragments of each biopsy were given concentrations of 0 (control), 10, 50, 100 and 200 μM RES for 21 days in 3D culture condition using fibrin as an extracellular matrix. Scoring methods were used for tissue changes, including; cellular invasion, monolayer formation and angiogenesis. Nitric oxide (NO) was measured using Griess's reaction, and quantitative real-time polymerase chain reaction (qRT-PCR) was used to evaluate the apoptotic gene expression.The mean of growth scores of endometriotic and endometrial tissue showed a significant dose dependent inhibition (P < 0.05). The levels of NO also significantly decreased in different groups. Apoptotic genes (P53, Bax, Bcl2 and caspase 3) and Sirt1 showed a significant increase in various concentrations of RES in both tissues (P < 0.05).RES exert dose- and time-dependent inhibitory effects on human endometrial tissue, and its higher doses suggested it as a natural supplement to inhibit the growth and treatment of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (51)
- Apoptosis induction of human endometriotic epithelial and stromal cells by noscapine via openalex
- A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model via openalex
- Endometriosis and Ovarian Cancer: an Integrative Review (Endometriosis and Ovarian Cancer) via openalex
- Endometriosis: the role of neuroangiogenesis via openalex
- Letrozole stimulates the growth of human endometrial explants cultured in three-dimensional fibrin matrix via openalex
- Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats via openalex
- Resveratrol and endometriosis: In vitro and animal studies and underlying mechanisms (Review) via openalex
- Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro via openalex
- Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways via openalex
- Three-dimensional in vitro culture of endometrial explants mimics the early stages of endometriosis via openalex
- W2108353107 via openalex
- W2113713934 via openalex
- W2125911601 via openalex
- W2126924400 via openalex
- W2136263732 via openalex
- W2156057711 via openalex
- W2169247999 via openalex
- W2213516770 via openalex
- W2288153191 via openalex
- W2298188977 via openalex
- W2330966147 via openalex
- W2581726363 via openalex
- W2588494698 via openalex
- W2749147610 via openalex
- W2908195152 via openalex
- W3145190636 via openalex
- W4300623566 via openalex
- W4389425200 via openalex
- W6635754692 via openalex
- W6638633797 via openalex
- W6678627715 via openalex
- W6680261372 via openalex
- W6696042671 via openalex
- W6697291781 via openalex
- W6702005583 via openalex
- W6728077010 via openalex
- W6732729624 via openalex
- W6757200917 via openalex
- W6844568866 via openalex
- W6987024935 via openalex
- W1596474287 via openalex
- W7017595827 via openalex
- W1838083570 via openalex
- W1964923339 via openalex
- W1972489193 via openalex
- W1986883507 via openalex
- W2020433921 via openalex
- W2031213396 via openalex
- W2042643475 via openalex
- W2060760516 via openalex
- W2097977979 via openalex
Cited by (25)
- Multi-Target Modulation of Interconnected Pathogenetic Pathways by Natural Bioactive Compounds in Endometriosis 2026
- Multi-Target Modulation of Interconnected Pathogenetic Pathways by Natural Bioactive Compounds in Endometriosis 2026
- Revisiting endometriosis management: Polyphenols as alternative therapeutic candidates 2026
- Polyphenols as Modulators of Oxidative Stress and Inflammation in Endometriosis: Molecular Mechanisms and Clinical Perspectives 2026
- Resveratrol as a protective and ameliorative agent in endometriosis 2026
- Polyphenols as Modulators of Oxidative Stress and Inflammation in Endometriosis: Molecular Mechanisms and Clinical Perspectives 2026
- Phytoestrogens: A Promising Therapeutic Approach for Endometriosis Management, Insights from Preclinical and Clinical Studies 2025
- Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications 2025
- Phytochemicals in the Management of Polycystic Ovary Syndrome, Endometriosis, and Menstrual Irregularities 2025
- Systems Pharmacology Model Predicts Zinc and Copper Can Be Repurposed as Endometriosis Therapies 2025
- Molecular Mechanism of Resveratrol and Its Therapeutic Potential on Female Infertility 2024
- Endometriosis-associated pain and new therapeutic options: A review 2023
- Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway 2023
- The effect of two anti-inflammatory dietary components, omega-3 and resveratrol, on endometriosis 2023
- Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis 2023
- Impact of curcumin, quercetin, or resveratrol on the pathophysiology of endometriosis: A systematic review 2022
- Evidence Supporting the Diethylstilbestrol Induction of Endometriosis Via Immune-Inflammatory Pathway in Rat Model 2022
- The Phytochemical Profile and Biological Activity of Malva neglecta Wallr. in Surgically Induced Endometriosis Model in Rats 2022
- Resveratrol impairs cellular mechanisms associated with the pathogenesis of endometriosis 2022
- Copaiba Oil Resin Exerts an Additive Effect to Babassu Oil on Behavioral Changes in Human Endometriotic Cell Cultures 2022
- Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives 2021
- Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in aRat Model 2021
- Endometriosis and Phytoestrogens: Friends or Foes? A Systematic Review 2021
- Faculty Opinions recommendation of Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives. 2021
- Influência Da Nutrição Em Mulheres Com Endometriose: Revisão De Literatura 2021
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:28:33.187078+00:00
- unpaywall
- last seen: 2026-10-13T06:25:51.201866+00:00
License: CC0
· commercial use OK